Expert Point of View: Julie Margenthaler, MD, FACS

Get Permission

Error loading Partial View script (file: ~/Views/MacroPartials/TAP Article Portrait Widget.cshtml)

JULIE MARGENTHALER, MD, FACS, a breast surgeon at Washington University School of Medicine and American Society of Breast Surgeons Communications Committee Chair, highlighted the importance of exploring clinical endpoints outside of a survival advantage. 

“While numerous studies have shown the benefits of screening mammography, they typically focus on a reduction in mortality,” said Dr. Margenthaler. “This is a large study that ties regular screening to hard data on the type of treatment required. Surprisingly, we continue to see conflicting data on the benefits of screening mammography for women less than 50 years of age.” ■

DISCLOSURE: Dr. Margenthaler reported no conflicts of interest. 

Related Articles

Regular Mammograms Linked to Less Aggressive Treatment in Patients With Breast Cancer

A STUDY evaluating the impact of breast cancer screening has shown that the benefits of regular mammograms extend well beyond reduced mortality. According to data presented at the American Society of Breast Surgeons (ASBrS) 2018 Annual Meeting, women with breast cancer who underwent regular...




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.